Archives of Virology

, Volume 163, Issue 5, pp 1179–1185 | Cite as

Investigation of the effects of a prevention of mother-to-child HIV transmission program among Iranian neonates

  • Farah Bokharaei-Salim
  • Saeed Kalantari
  • Zahra Gholamypour
  • AliReza Najafi
  • Hossein Keyvani
  • Maryam Esghaei
  • Seyed Hamidreza Monavari
  • Khadijeh Khanaliha
  • Mohammad-Navid Bastani
  • Atousa Fakhim
  • Saba Garshasbi
Original Article


Human immunodeficiency virus (HIV) infection is mostly spreading in developing countries. One of the most important pathways of HIV infection in these nations is the vertical route, from mother to infant. Therefore, this study evaluated the effectiveness of the prevention of mother-to-child transmission (PMTCT) program for HIV among Iranian neonates born to HIV-positive mothers. A total of 54 neonates born to HIV-1 positive mothers, all of whom were in a PMTCT program for HIV, as per the Iranian guidelines, were enrolled in this descriptive cross sectional study from March 2014 to July 2017. After RNA extraction of a plasma specimen, HIV-1 viral load was tested by an Artus HIV-1 RG RT-PCR Kit. Out of 54 evaluated neonates, 32 (59.3%) were male. The mean age of the HIV-infected mothers was 30.1 ± 5.4 (range: 19–47) years, and 36 (66.7%) of the mothers were in the age group 26–34 years. In the present study, it was found that none of the neonates whose mothers had previously entered PMTCT programs had HIV. 15 children were found who were born to HIV-positive mothers who had not entered the PMTCT program. Three of these children were infected with HIV (CRF35_AD), and none of them carried HIV-1 variants with SDRMs. The results of this study indicate that if HIV-positive pregnant women enter the PMTCT program for HIV, they can realistically hope to give birth to a non-infected child.



The authors would like to thank all of the candidates who generously enrolled in this research.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical considerations

Ethical approval for this study was obtained from the local ethics committee of the IUMS, Tehran, Iran, that is accordance with Helsinki declaration. All of the parents of the infants were informed about the current study, with a written consent form received prior to their enrollment. All the experiments were carried out in the HIV Laboratory of National Centre, Deputy of Health, IUMS, Tehran, Iran.

Sources of funding

The current study was funded by Research Deputy of Iran University of Medical Sciences, Tehran, Iran with Grant Number 26050.


  1. 1.
    Lilian RR, Kalk E, Bhowan K, Berrie L, Carmona S, Technau K et al (2012) Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age. J Clin Microbiol 50(7):2373–2377CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Bokharaei-Salim F, Keyvani H, Esghaei M, Zare-Karizi S, Dermenaki-Farahani SS, Hesami-Zadeh K et al (2016) Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection. J Med Virol 88(11):1960–1966CrossRefPubMedGoogle Scholar
  3. 3.
    Poudel P, Pokharel R, Chitlangia M, Chaudhary S (2014) Profile of HIV infected children: a hospital based study at Eastern Nepal. Asian Pac J Trop Dis 4(3):169–175CrossRefPubMedCentralGoogle Scholar
  4. 4.
    UNAIDS (2016) Fact sheet—latest statistics on the status of the AIDS epidemic 2016. http://www.unaidsorg/en/resources/fact-sheet. Accessed 1 Aug 2016
  5. 5.
    Craig AP, Thein HH, Zhang L, Gray RT, Henderson K, Wilson D et al (2014) Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populations. J Int AIDS Soc 17:18822CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Ishikawa N, Newman L, Taylor M, Essajee S, Pendsee R, Ghidinellif M (2016) Elimination of mother-to-child transmission of HIV and syphilis in Cuba and Thailand. Bull World Health Organ 94(11):787CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    De Cock KM, Fowler MG, Mercier E, de Vincenzi I, Saba J, Hoff E et al (2000) Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA 283(9):1175–1182CrossRefPubMedGoogle Scholar
  8. 8.
    Behboodi-Moghadam Z, Khalajinia Z, Nasrabadi AR, Mohraz M, Gharacheh M (2016) Pregnancy through the lens of Iranian women with HIV: a qualitative study. J Int Assoc Provid AIDS Care 15(2):148–152CrossRefPubMedGoogle Scholar
  9. 9.
    World Health Organization (2016) Global report: UNAIDS report on the global AIDS epidemic. World Health Organization, GenevaGoogle Scholar
  10. 10.
    Clinical guidelines for the Islamic Republic of Iran, Ministry of Health and Medical Education, Vice Chancellor for Health, Center. IDM (2014) Prevention of HIV transmission from mother to childGoogle Scholar
  11. 11.
    Movahedi Z, Mahmoudi S, Pourakbari B, Keshavarz Valian N, Sabouni F, Ramezani A et al (2016) Epidemiology of children with acquired immune deficiency syndrome (stage 3): a referral hospital-based study in Iran. J Med Virol 88(1):64–68CrossRefPubMedGoogle Scholar
  12. 12.
    Remme M, Siapka M, Vassall A, Heise L, Jacobi J, Ahumada C et al (2014) The cost and cost-effectiveness of gender-responsive interventions for HIV: a systematic review. J Int AIDS Soc. 17:19228CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Nduati EW, Hassan AS, Knight MG, Muema DM, Jahangir MN, Mwaringa SL et al (2015) Outcomes of prevention of mother to child transmission of the human immunodeficiency virus-1 in rural Kenya—a cohort study. BMC Pub Health 15:1008CrossRefGoogle Scholar
  14. 14.
    Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O’Sullivan MJ et al (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331(18):1173–1180CrossRefPubMedGoogle Scholar
  15. 15.
    Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C et al (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29(5):484–494CrossRefPubMedGoogle Scholar
  16. 16.
    World Health Organization (2015) Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, World Health OrganizationGoogle Scholar
  17. 17.
    Rodman JH, Flynn PM, Robbins B, Jimenez E, Bardeguez AD, Rodriguez JF et al (1999) Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants. J Infect Dis 180(6):1844–1850CrossRefPubMedGoogle Scholar
  18. 18.
    Lahoz R, Noguera A, Rovira N, Catala A, Sanchez E, Jimenez R et al (2010) Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen. Pediatr Infect Dis J. 29(4):376–379PubMedGoogle Scholar
  19. 19.
    Vahabpour R, Bokharaei-Salim F, Kalantari S, Garshasbi S, Monavari SH, Esghaei M et al (2017) HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals. Adv Virol 162(6):1477–1485Google Scholar
  20. 20.
    Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M et al (2009) Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS ONE 4(3):e4724CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Organization WH. Treatment of children living with HIV WHO; 2016 [cited May 2016]Google Scholar
  22. 22.
    Organization WH (2017) Research for and AIDS free generation: a global research agenda for paediatric HIVGoogle Scholar
  23. 23.
    Khazaei S, Mansori K, Ayubi E (2016) Challenges and proposed actions for HIV/AIDS control among children in Iran. Int J Pediatr 4(8):2295–2297Google Scholar
  24. 24.
    Majid T, Farhad Y, Sorour A, Soheila A, Farnaz F, Hojjat Z et al (2010) Preventing mother-to-child transmission of HIV/AIDS: do Iranian pregnant mothers know about it? J Reprod Infertil 11(1):53–57PubMedGoogle Scholar
  25. 25.
    Olugbenga-Bello A, Adebimpe W, Osundina F, Abdulsalam S (2013) Perception on prevention of mother-to-child-transmission (PMTCT) of HIV among women of reproductive age group in Osogbo, Southwestern Nigeria. Int J Women’s Health 5:399–405CrossRefGoogle Scholar
  26. 26.
    National AIDS Committee Secretariat MoHaME (2015) Islamic Republic of Iran AIDS Progress Report, On Monitoring of the United Nations General Assembly Special Session on HIV and AIDSGoogle Scholar
  27. 27.
    Ishikawa N, Newman L, Taylor M, Essajee S, Pendse R, Ghidinelli M (2016) Elimination of mother-to-child transmission of HIV and syphilis in Cuba and Thailand. Bull World Health Org 94(11):787-ACrossRefGoogle Scholar
  28. 28.
    Lindegren ML, Byers RH Jr, Thomas P, Davis SF, Caldwell B, Rogers M et al (1999) Trends in perinatal transmission of HIV/AIDS in the United States. JAMA 282(6):531–538CrossRefPubMedGoogle Scholar
  29. 29.
    Memarnejadian A, Menbari S, Mansouri SA, Sadeghi L, Vahabpour R, Aghasadeghi MR et al (2015) Transmitted drug resistance mutations in antiretroviral-naive injection drug users with chronic HIV-1 infection in Iran. PLoS ONE 10(5):e0126955CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Ghafari S, Memarnejadian A, Samarbaf-Zadeh A, Mostafavi E, Makvandi M, Salmanzadeh S et al. (2017) Prevalence of HIV-1 transmitted drug resistance in recently infected, treatment-naive persons in the Southwest of Iran, 2014–2015. Arch Virol 162(9):2737–2745CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  • Farah Bokharaei-Salim
    • 1
    • 2
  • Saeed Kalantari
    • 3
  • Zahra Gholamypour
    • 4
  • AliReza Najafi
    • 2
  • Hossein Keyvani
    • 1
  • Maryam Esghaei
    • 1
  • Seyed Hamidreza Monavari
    • 1
  • Khadijeh Khanaliha
    • 5
  • Mohammad-Navid Bastani
    • 1
  • Atousa Fakhim
    • 6
  • Saba Garshasbi
    • 2
  1. 1.Department of Virology, School of MedicineIran University of Medical SciencesTehranIran
  2. 2.HIV Laboratory of National CenterIran University of Medical SciencesTehranIran
  3. 3.Departments of Infectious Diseases and Tropical MedicineIran University of Medical SciencesTehranIran
  4. 4.Iran University of Medical SciencesTehranIran
  5. 5.Research Center of Pediatric Infectious Diseases, Institute of Immunology and Infectious DiseasesIran University of Medical SciencesTehranIran
  6. 6.Department of Architectural Engineering, Faculty of EngineeringIslamic Azad UniversityTehranIran

Personalised recommendations